FibroBiologics Secures $100 Million to Support Cell Therapy

FibroBiologics signed an agreement with GEM Global, a private investment group, to provide FibroBiologics with up to $100 million over a 36-month term following a public listing of FibroBiologics common stock.

FibroBiologics is a regenerative medicine company developing a solution for chronic disease treatment using fibroblast cells. Currently,...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us